ORIENT BIO Inc. (KRX:002630)

ORIENT BIO Balance Sheet

Financials in millions KRW. Fiscal year is April - March.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Cash & Equivalents	10,940	2,350	9,170	24,438	19,010
Short-Term Investments	800	801	801	10,811	811
Cash & Short-Term Investments	11,740	3,151	9,971	35,249	19,821
Cash Growth	272.61%	-68.40%	-71.71%	77.84%	114.03%
Accounts Receivable	7,017	9,406	6,721	17,797	15,729
Other Receivables	1,330	672.1	297.79	3,731	4,001
Receivables	9,416	10,887	7,119	23,339	20,942
Inventory	5,928	8,102	10,011	31,255	28,634
Prepaid Expenses	360.28	41.52	-	-	-
Other Current Assets	1,616	1,548	5,235	6,022	7,937
Total Current Assets	29,060	23,729	32,336	95,865	77,333
Property, Plant & Equipment	31,321	40,242	41,669	61,911	54,853
Long-Term Investments	5,652	1,759	5,804	1,087	795.68
Goodwill	0	0	0	7,988	10,077
Other Intangible Assets	274.53	285.6	253.37	745.98	893.3
Long-Term Deferred Charges	200	1,923	2,393	1,884	2,539
Other Long-Term Assets	2,048	813.02	922.18	15,668	15,490
Total Assets	71,519	75,939	84,089	190,031	165,876
Accounts Payable	759.97	837.39	639.18	11,443	10,426
Accrued Expenses	370.14	316.26	285.76	684.84	922.62
Short-Term Debt	4,927	5,037	5,941	51,618	24,212
Current Portion of Long-Term Debt	1,540	48.9	2,259	296.3	17,063
Current Portion of Leases	544.45	687.15	-	-	-
Current Income Taxes Payable	-	-	-	13.24	13.39
Other Current Liabilities	7,089	6,607	5,793	26,424	4,023
Total Current Liabilities	15,230	13,533	14,918	90,479	56,661
Long-Term Debt	-	1,540	48.9	12,233	10,423
Long-Term Leases	1,095	2,280	-	-	-
Other Long-Term Liabilities	1,308	1,196	440.31	276.71	207.41
Total Liabilities	22,973	23,381	21,443	110,107	74,681
Common Stock	59,286	50,899	114,268	81,573	80,530
Additional Paid-In Capital	8,818	8,192	11,139	9,129	16,844
Retained Earnings	-19,731	-7,492	-61,338	-39,140	-34,935
Treasury Stock	-10.02	-10.02	-	-	-
Comprehensive Income & Other	182.11	967.74	718.66	1,162	1,112
Total Common Equity	48,545	52,558	64,787	52,724	63,551
Minority Interest	0.27	0.15	-2,141	27,200	27,643
Shareholders' Equity	48,545	52,558	62,646	79,923	91,195
Total Liabilities & Equity	71,519	75,939	84,089	190,031	165,876
Total Debt	8,107	9,593	8,249	64,147	51,698
Net Cash (Debt)	3,633	-6,442	1,722	-28,898	-31,877
Net Cash Per Share	32.09	-62.42	22.10	-402.43	-453.20
Filing Date Shares Outstanding	118.56	101.78	101.79	72.67	71.74
Total Common Shares Outstanding	118.56	101.78	101.79	72.67	71.74
Working Capital	13,830	10,196	17,417	5,386	20,672
Book Value Per Share	409.46	516.36	636.48	725.57	885.90
Tangible Book Value	48,270	52,272	64,534	43,989	52,581
Tangible Book Value Per Share	407.15	513.56	633.99	605.37	732.97
Land	3,256	3,359	3,261	6,728	5,501
Buildings	28,803	30,434	23,509	32,022	24,023
Machinery	4,796	4,822	1,798	8,853	9,154
Construction In Progress	650.92	2,968	6,948	6,690	5,585

Source: S&P Global Market Intelligence. Standard template. Financial Sources.